Scinovex
article Open AccessTop 1% cited

Transient expression of FOXP3 in human activated nonregulatory CD4 <sup>+</sup> T cells

European Journal of Immunology · 2006 · Vol. 37(1) · pp. 129–138
Jun WangAndreea Ioan‐FacsinayEllen I. H. van der VoortT. HuizingaRené E. M. Toes

Abstract

Foxp3 plays a key role in CD4+ CD25+ T(reg) cell function in mice and represents a specific marker for these cells. Despite the strong association between FOXP3 expression and regulatory function in fresh human T cells, little is known about the dynamics of endogenous FOXP3 expression and its relation to the suppressive function in activated human T cells. Here, we addressed the dynamics of FOXP3 expression during human CD4+ T cell activation by plate-bound anti-CD3 Ab as well as the relationship between its expression and regulatory function at the single-cell level. Our data show that FOXP3 is expressed in a high percentage of activated T cells after in vitro stimulation of human CD4+ CD25- cells. FOXP3 expression is strongly associated with hyporesponsiveness of activated T cells, but is not directly correlated with their suppressive capabilities, as we demonstrate that it is also expressed in activated nonsuppressive T cells. However, in this nonsuppressive T cell population, FOXP3 expression is transient, while it is stably expressed in activated T cells that do display suppressive function, and in natural CD4+ CD25++ T(reg) cells. These data indicate that expression of endogenous FOXP3, in humans, is not sufficient to induce regulatory T cell activity or to identify T(reg) cells.

T-cell and B-cell ImmunologyImmune Cell Function and InteractionImmunotherapy and Immune ResponsesFOXP3IL-2 receptorBiologyCell biologyT cellInterleukin 21Regulatory T cellPopulationMolecular biologyImmunology

MeSH terms

Cells, CulturedHumansLymphocyte ActivationTime FactorsCD4-Positive T-LymphocytesT-Lymphocyte SubsetsResting Phase, Cell CycleCytokinesSelf ToleranceCoculture TechniquesCell ProliferationT-Lymphocytes, RegulatoryForkhead Transcription FactorsInterleukin-2 Receptor alpha Subunit
Citations
988
FWCI
27.12
field-weighted impact
References
44
Percentile
100%
vs. same field & year
Citations per year
Cited by
Targeting Treg cells in cancer immunotherapy
European Journal of Immunology · 2019 · 481 citations
Regulatory T Cells: Mechanisms of Differentiation and Function
Annual Review of Immunology · 2007 · 2,780 citations
Molecular Mechanisms of Treg-Mediated T Cell Suppression
Frontiers in Immunology · 2012 · 761 citations
DNA methylation controls <i>Foxp3</i> gene expression
European Journal of Immunology · 2008 · 760 citations
How regulatory T cells work
Nature reviews. Immunology · 2008 · 3,325 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.